ZIMMER BIOMET HOLDINGS, INC. Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet · last filed 2018-02-27
- ZIMMER BIOMET HOLDINGS, INC. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2016-12-31 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2016-09-30 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2016-06-30 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2016-03-31 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2017 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2016 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2015 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2014 was $0.00.
| Period end | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 3 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 6 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 9 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-27 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-08 | $0.00 derived: sum of 2 quarters · filed 2016-11-08 | $0.00 10-Q · filed 2016-11-08 | $0.00 derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $0.00 derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $0.00 derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-08 | $0.00 10-Q · filed 2016-11-08 | $0.00 derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | $0.00 derived: sum of 3 quarters · filed 2017-03-01 | $0.00 derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $0.00 derived: sum of 3 quarters · filed 2017-03-01 | $0.00 derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $0.00 derived: sum of 3 quarters · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-07 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 10-K · filed 2016-02-29 |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-05 | $0.00 derived: sum of 2 quarters · filed 2014-11-05 | $0.00 10-Q · filed 2014-11-05 | |
| 2013-06-30 | $0.00 10-Q · filed 2014-08-07 | $0.00 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-06 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-02-23 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |